CyFlow™ NK1.1 Low Endotoxin
| Alternative Name: | CD161bc |
| Antibody: | Yes |
| Antigen: | NK1.1 |
| Application: | Flow cytometry, Functional assays, Immunohistochemistry (frozen sections), Immunoprecipitation |
| Clonality: | monoclonal |
| Clone: | PK136 |
| Field of Interest: | Immunophenotyping, MHC |
| Format/Fluorochrome: | Low Endotoxin |
| Isotype: | IgG2a |
| Regulatory Status: | RUO |
| Source Species: | Mouse |
| Target Species: | Mouse |
| Product number: | BL131384 |
For Research Use Only
| Concentration Unit | mg/mL |
| Concentration | 1 |
| Quantity | 0.1 mg |
| Volume | 0.1 mL |
| Immunogen | NK1-positive murine splenic and bone marrow cells |
| Background Information | NK1.1 (CD161bc and also known as NKRP1, Ly55c, or Ly59) is a cell surface antigen expressed on NK cells and NK-T cells of certain mouse strains, which is being used for identification or antibody-mediated depletion of these cells in the respective strains. This antigen participates in NK cell activation, including production of interferon gamma, and release of cytotoxic granules. |
| Storage Buffer | The reagent is provided in azide-free phosphate buffered saline (PBS) solution, pH ≈7.4; 0.2 µm filter sterilized. Endotoxin level is less than 0.01 EU/µg of the protein, as determined by the LAL test. |
| Storage | Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze. |
| Stability | Do not use after expiration date stamped on vial label. |
| Wang M, Ellison CA, Gartner JG, HayGlass KT: Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen‑stimulated cytokine and antibody responses. J Immunol. 1998 Feb 1; 160(3):1098‑105. < PMID: 9570522 > | Carroll JL, Nielsen LL, Pruett SB, Mathis JM: The role of natural killer cells in adenovirus‑mediated p53 gene therapy. Mol Cancer Ther. 2001 Nov; 1(1):49‑60. < PMID: 12467238 > | Símová J, Bubeník J, Bieblová J, Jandlová T: The role of NK1.1+ cells in the protection against MHC class I+ HPV16‑associated tumours. Folia Biol (Praha). 2004; 50(6):200‑2. < PMID: 15709715 > | Kulesza J, Hoser G, Wasilewska D, Kawiak J: NK cell depletion and recovery in SCID mice treated with anti‑NK1.1 antibody. Folia Histochem Cytobiol. 2006; 44(2):93‑6. < PMID: 16805133 > | Takahashi S, Kawamura T, Kanda Y, Taniguchi T, Nishizawa T, Iiai T, Hatakeyama K, Abo T: Activation of CD1d‑independent NK1.1+ T cells in the large intestine by Lactobacilli. Immunol Lett. 2006 Jan 15; 102(1):74‑8. < PMID: 16107279 > | Carlyle JR, Mesci A, Ljutic B, Belanger S, Tai LH, Rousselle E, Troke AD, Proteau MF, Makrigiannis AP: Molecular and genetic basis for strain‑dependent NK1.1 alloreactivity of mouse NK cells. J Immunol. 2006 Jun 15; 176(12):7511‑24. < PMID: 16751398 > | Fang M, Lanier LL, Sigal LJ: A role for NKG2D in NK cell‑mediated resistance to poxvirus disease. PLoS Pathog. 2008 Feb 8; 4(2):e30. < PMID: 18266471 > | Laffont S, Seillet C, Ortaldo J, Coudert JD, Guéry JC: Natural killer cells recruited into lymph nodes inhibit alloreactive T‑cell activation through perforin‑mediated killing of donor allogeneic dendritic cells. Blood. 2008 Aug 1; 112(3):661‑71. < PMID: 18505782 > | GeurtsvanKessel CH, Bergen IM, Muskens F, Boon L, Hoogsteden HC, Osterhaus AD, Rimmelzwaan GF, Lambrecht BN: Both conventional and interferon killer dendritic cells have antigen‑presenting capacity during influenza virus infection. PLoS One. 2009 Sep 28; 4(9):e7187. < PMID: 19784375 > | Joncker NT, Shifrin N, Delebecque F, Raulet DH: Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med. 2010 Sep 27; 207(10):2065‑72. < PMID: 20819928 >